HOME >> BIOLOGY >> NEWS
Ears can't hear when special sensory cells don't stay 'quiet'

und this was not the case in the inner ear, where the loss of Ink4d alone in mice lead to failed attempts at cell division and, ultimately, progressive death of sensory hair cells.

The researchers studied mice that lacked both copies of Ink4d (Ink4d -/- mice; normally, one copy of each gene is inherited from each parent). Using biochemical techniques that highlighted hair cells under the microscope, they observed hair cell loss in mice that were 2.5 weeks old. When the Ink4d -/- mice were seven weeks old, hair cell loss had progressed even further. Specifically, the innermost of four rows of sensory hair cells suffered a loss of 43.3% of cells, and the three outer rows suffered losses of 27.8%, 8.1%, and 8.5%, respectively. Mice that had both copies of the Ink4d gene (Ink4d +/+) did not suffer loss of sensory hair cells in the organ of Corti.

The researchers also used sound measurements to test how well the mice responded to sound. One test, called "distortion product otoacoustic emission" (DPOAE) measures sounds generated by the hair cells themselves in response to being stimulated by sound waves coming into the inner ear. The DPOAE test was performed at weeks 7 and 15 in both Ink4d +/+ and Ink4d -/- mice. The ears of normal mice produced normal responses to sound waves entering the ear, but the ears of mice lacking Ink4d did not respond to this stimulation.

In addition, the investigators used a test called "auditory brainstem response" (ABR) to compare the nerve response to sound in mice with and without Ink4d. The ABR test studies the electric impulses of the auditory nerve pathways from the ear in response to clicks or short bursts of sound. Specifically, it measures the so-called "sound pressure level (SPL)," or the strength a stimulus must be before there is a measurable response in these nerves. At 7 weeks of age the Ink4d -/- mice had responses similar to Ink4d +/+ mice. However, by week 15, the sound level had to be increased signi
'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
1-May-2003


Page: 1 2 3 4

Related biology news :

1. Assisted reproduction cant compensate for waiting too long to start a family
2. When blood cant get to brain, special CT scan helps
3. Mutant biological machine makes proteins but cant let go
4. Marine reserves cant do it all: Sea otters vs. red abalone
5. Bacteria cant do their thing if they dont have cling
6. Targeting enzymes that immortalize cancer cells: if you cant turn them off, round them up
7. The bodys production of melatonin may be the reason why the elderly cant get a good nights sleep
8. Why some people just cant seem to pay attention
9. Researchers find clues about how antibodies specialize
10. Reading hexametric rhyme supports cardiac synchronization, especially after a heart attack
11. Bigger isnt always better--especially if youre a rodent

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ears can hear when special sensory cells don stay quiet

(Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., a ... by the United States Patent and Trademark Office (USPTO) ... process leverages TAKE Solutions, Clinical Accelerators to reduce the ... (when compared to standardization without the accelerators), thus reducing ... At the heart of the patented ...
(Date:6/24/2015)... June 24, 2015 This report provides market ... next six years. It contains an analysis of the ... with their impact from the short, medium, and long ... the industry, market, and technology trends that currently, prevail ... of concerned authorities to efficiently manage the increasing marine ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... ... designer, manufacturer and supplier, announces the launch of their 2nd generation cell therapy ... the current miniPOD CT, but it also represents a new POD® design. ...
(Date:7/29/2015)... 2015  AmnioChor Inc., an early stage biotech startup ... to announce that the Musculoskeletal Transplant Foundation of ... in their seed round of development of the proprietary ... AmnioChor,s technology allows cryopreservation of the ... cells living within those tissues. Amnion is a well-established ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: